Avandia Sales Slumped Over Heart Risk Reports
On April 25th, 2012, Reuters reported that Avandia sales are collapsing as the drug has been linked to heart risks. Avandia, a popular drug manufactured by GlaxoSmithKline, was first approved by the FDA in 1999 to treat Type 2 diabetes in adult patients. GlaxoSmithKline’s first-quarter 2012 sales on the metabolic sector are down 60 percent ...